Literature DB >> 28728989

Caution with Use of the EPIC-50 Urinary Bother Scale: How Voiding Dysfunction Modifies its Performance.

Lin Yang1, Adam S Kibel2, Graham A Colditz3, Ratna Pakpahan3, Kellie R Imm3, Sonya Izadi3, Robert L Grubb4, Kathleen Y Wolin5, Siobhan Sutcliffe3.   

Abstract

PURPOSE: We evaluated agreement between patient reported urinary function and bother, and sexual function and bother in patients treated with radical prostatectomy to help inform possible nonfunctional, modifiable mechanisms for patient bother.
MATERIALS AND METHODS: Patients were recruited from 2011 to 2014 at Washington University, and Brigham and Women's Hospital. Urinary and sexual outcomes were assessed by EPIC-50 (Expanded Prostate Cancer Index Composite-50) before, 5 weeks and 12 months after radical prostatectomy. Spearman rank correlation coefficients and agreement/disagreement categories were used to describe the relation between function and bother.
RESULTS: Despite moderate to good agreement between function and bother (urinary r = 0.51-0.69 and sexual r = 0.65-0.80) discordant groups were observed. In the urinary domain these groups were men disproportionately bothered by function at baseline (16.9%) and 12 months after radical prostatectomy (6.1%) and men less bothered by function 5 weeks (26.8%) and 12 months (9.9%) after radical prostatectomy. Discordant groups in the sexual domain were men less bothered by function at baseline (20.8%), and 5 weeks (21.1%) and 12 months (15.7%) after radical prostatectomy. Splitting the urinary bother scale into 2 subscales, including one for incontinence related bother to complement the urinary function scale which measures only incontinence, and one for voiding dysfunction related bother yielded considerably better agreement (urinary function and incontinence related bother r = 0.78-0.83). Factors contributing to the group less bothered by sexual function were unclear.
CONCLUSIONS: When using EPIC-50, investigators should consider splitting the urinary bother scale by the relation to incontinence to prevent distortions of function-bother and comparisons before vs after radical prostatectomy by coexisting voiding dysfunction.
Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  erectile dysfunction; patient outcome assessment; prostatectomy; prostatic neoplasms; urinary incontinence

Mesh:

Year:  2017        PMID: 28728989      PMCID: PMC5693702          DOI: 10.1016/j.juro.2017.07.041

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  29 in total

1.  Quality of life and prostate cancer treatment.

Authors:  M J Barry
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

2.  Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments.

Authors:  Emily A Vertosick; Andrew J Vickers; Janet E Cowan; Jeanette M Broering; Peter R Carroll; Matthew R Cooperberg
Journal:  J Urol       Date:  2017-03-22       Impact factor: 7.450

3.  Patient-perceived satisfaction after definitive treatment for men with high-risk prostate cancer: radical prostatectomy vs. intensity-modulated radiotherapy with androgen deprivation therapy.

Authors:  Shinya Yamamoto; Hitoshi Masuda; Shinji Urakami; Yasuhisa Fujii; Kimihiko Sakamoto; Takuyo Kozuka; Masahiko Oguchi; Iwao Fukui; Junji Yonese
Journal:  Urology       Date:  2014-10-30       Impact factor: 2.649

4.  Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument.

Authors:  Brent K Hollenbeck; Rodney L Dunn; John T Wei; James E Montie; Martin G Sanda
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

5.  Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment.

Authors:  Peter Chang; Meredith M Regan; Montserrat Ferrer; Ferran Guedea; Dattatraya Patil; John T Wei; Larry A Hembroff; Jeff M Michalski; Chris S Saigal; Mark S Litwin; Daniel A Hamstra; Irving D Kaplan; Jay P Ciezki; Eric A Klein; Adam S Kibel; Howard M Sandler; Rodney L Dunn; Catrina M Crociani; Martin G Sanda
Journal:  J Urol       Date:  2016-09-02       Impact factor: 7.450

6.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

Authors:  J T Wei; R L Dunn; M S Litwin; H M Sandler; M G Sanda
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

7.  Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors.

Authors:  Ravishankar Jayadevappa; Stanley Bruce Malkowicz; Marsha Wittink; Alan J Wein; Sumedha Chhatre
Journal:  Health Serv Res       Date:  2012-03-14       Impact factor: 3.402

8.  Urinary Bother as a Predictor of Postsurgical Changes in Urinary Function After Robotic Radical Prostatectomy.

Authors:  Gregory Murphy; Peter Haddock; Hoyt Doak; Max Jackson; Ryan Dorin; Anoop Meraney; Stuart Kesler; Ilene Staff; Joseph R Wagner
Journal:  Urology       Date:  2015-07-10       Impact factor: 2.649

Review 9.  Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.

Authors:  A S Polackwich; D A Shoskes
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-03-08       Impact factor: 5.554

Review 10.  Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.

Authors:  Ronald C Chen; Peter Chang; Richard J Vetter; Himansu Lukka; William A Stokes; Martin G Sanda; Deborah Watkins-Bruner; Bryce B Reeve; Howard M Sandler
Journal:  J Natl Cancer Inst       Date:  2014-07-08       Impact factor: 13.506

View more
  2 in total

1.  On the Relationship Between Erectile Function and Sexual Distress in Men with Prostate Cancer.

Authors:  Lauren M Walker; Pablo Santos-Iglesias
Journal:  Arch Sex Behav       Date:  2020-02-18

2.  Effectiveness and Prognosis: Drainage Skin-Bridge Sparing Surgery Combined with Fistulotomy versus Fistulotomy Only in the Treatment of Anal Fistula.

Authors:  Xiao Wang; Chunliang Wang; Ruihua Qi
Journal:  J Healthc Eng       Date:  2021-11-28       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.